Literature DB >> 11255811

Misoprostol administration in medical abortion. A comparison of three regimens.

E R Wiebe1.   

Abstract

OBJECTIVE: To determine the best regimen for using misoprostol after methotrexate in medical abortion with respect to outcome and side effects. STUDY
DESIGN: In a cohort study, we compared vaginal misoprostol in one cohort of 134 women who used 800 micrograms dry tablets with 99 women who used 600 micrograms wet and 197 women who used 800 micrograms wet. These cohorts were compared with respect to outcome and side effects.
RESULTS: The "dry" group had fewer completed abortions by day 8 (55.2% as compared to 69.7% and 71.1%, P = .008) but similar surgery rates. The dry group also had fewer side effects, especially fever and chills (4.5% as compared to 25.3% and 40.6%, P = .0001) and vomiting (8.2% as compared to 16.2% and 20.3%, P = .01).
CONCLUSION: Of the three methods, the one consisting of 600 micrograms of wet misoprostol is the most effective for early completion of abortion and has the fewest side effects.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11255811

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  4 in total

1.  Efficacy of Misoprostol Alone for First-Trimester Medical Abortion: A Systematic Review.

Authors:  Elizabeth G Raymond; Margo S Harrison; Mark A Weaver
Journal:  Obstet Gynecol       Date:  2019-01       Impact factor: 7.661

Review 2.  Medical methods for first trimester abortion.

Authors:  Jing Zhang; Kunyan Zhou; Dan Shan; Xiaoyan Luo
Journal:  Cochrane Database Syst Rev       Date:  2022-05-24

Review 3.  Medical methods for first trimester abortion.

Authors:  Regina Kulier; Nathalie Kapp; A Metin Gülmezoglu; G Justus Hofmeyr; Linan Cheng; Aldo Campana
Journal:  Cochrane Database Syst Rev       Date:  2011-11-09

4.  Effect of vaginal washing before Misoprostol insertion on cervical ripening before induction of labor: A randomized single-blind clinical trial.

Authors:  Roya Kabodmehri; Seyedeh Hajar Sharami; Forozan Milani; Fatemeh Hosseinzadeh; Seyedeh Fatemeh Dalil Heirati; Zakie Bakhshipour; Zahra Pourhabibi
Journal:  Health Sci Rep       Date:  2022-02-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.